| Literature DB >> 16274990 |
Ariamala Gopalsamy1, Alexis Aplasca, Gregory Ciszewski, Kaapjoo Park, John W Ellingboe, Mark Orlowski, Boris Feld, Anita Y M Howe.
Abstract
A novel class of HCV NS5B RNA dependent RNA polymerase inhibitors containing 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran scaffolds were designed and synthesized. Optimization of the alkyl substituent in the pyran ring showed preference for an n-propyl group, while 5,8-disubstitution pattern is preferred for the aromatic region. Analog 19 displayed potent activity with an IC(50) of 50 nM against HCV NS5B enzyme and was selective over a panel of polymerases.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16274990 DOI: 10.1016/j.bmcl.2005.08.114
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823